Stock Photo - 20 November 2023, NoW, Cologne: The Bayer Cross, the company's logo, shines on the Bayer site in Leverkusen. Bayer has discontinued a study with an important drug hopeful due to lack of efficacy. A Phase III study investigating the drug asundexiane in patients with atrial fibrillation and stroke risk was terminated prematurely, the company announced late on Sunday evening. Photo: Thomas Banneyer/dpa. - Cologne/NoW/Germany

@ 0.018 --> Keywords launching task... @ 0.018 --> GetKeywords: Getting cache @ 0.030 --> _srcset calculated @ 0.060 --> GetKeywords: Request cached? True @ 0.072 --> begin dades json... @ 0.079 --> begin waiting GetItemsAsync... @ 0.094 --> itemsController.Get() completed! @ 0.106 --> pricing done @ 0.107 --> Dades JSON completed! @ 0.107 --> Keywords task start waiting @ 0.122 --> GetKeywords: File obtained @ 0.122 --> GetKeywords: File to Json @ 0.130 --> GetKeywords: DocLastUpdate checked @ 0.130 --> GetKeywords: Cached item @ 0.131 --> GetKeywords: keywords ampliacion @ 0.131 --> Keywords task completed @ 0.142 --> Schema completed @ 0.142 --> Adobe ads... @ 0.142 --> Adobe ads done @ 0.143 --> controller done